Jade Therapeutics
company
About
Jade Therapeutics develops locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $153.64K
- Industries
- Biotechnology,Health Care,Medical,Visual Search
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.05M
Jade Therapeutics has raised a total of
$1.05M
in funding over 2 rounds. Their latest funding was raised on
Nov 25, 2014 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 25, 2014 | Grant | $0.90M | 1 |
National Science Foundation
|
— | Detail |
| Jun 12, 2013 | Grant | $153.64K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Jade Therapeutics is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
